Scrip Regulatory Affairs
The New EU Data Protection Regulation: What will the Impact be on the Life Sciences Industry?
March 2012
The EU Data Protection Regulation proposed by the European Commission in January will - if adopted in its current form - require pharmaceutical and medical device companies to adopt a new approach to data processing and data protection.
This article was published in the March 2012 issue of Scrip Regulatory Affairs.
Contacts
Capabilities
Suggested News & Insights
Sidley Advises Verdane in Its Partnership With SmartboxMarch 12, 2026The New Cyber Doctrine of the United States: The Trump Administration Issues Cyber Strategy and Executive Order Targeting CybercrimeMarch 10, 2026U.S. Office of the Comptroller of the Currency Proposes Comprehensive Supervisory Framework for Payment Stablecoins Under GENIUS ActMarch 6, 2026From Tallahassee to Phoenix: States Move to Enforce National Security Limits on Access to Americans’ Sensitive Personal DataMarch 5, 2026Generative AI and Privilege: Practical Lessons from Two Early Decisions and What Comes NextMarch 3, 2026Congress Considers Right to Repair Bill for Vehicle OwnersMarch 2, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory